Loading...

Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?

BACKGROUND: The benefit of adjuvant immunotherapy after nephrectomy in renal cell carcinoma (RCC) is controversial. The present study aimed to examine the possible benefit of adjuvant immunotherapy in various clinical settings. METHODS: We retrospectively reviewed 436 patients with pT1-3N0-2M0 RCC w...

Full description

Saved in:
Bibliographic Details
Published in:PLoS One
Main Authors: Taguchi, Satoru, Buti, Sebastiano, Fukuhara, Hiroshi, Otsuka, Masafumi, Bersanelli, Melissa, Morikawa, Teppei, Miyazaki, Hideyo, Nakagawa, Tohru, Fujimura, Tetsuya, Kume, Haruki, Igawa, Yasuhiko, Homma, Yukio
Format: Artigo
Language:Inglês
Published: Public Library of Science 2017
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5328261/
https://ncbi.nlm.nih.gov/pubmed/28241027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0172341
Tags: Add Tag
No Tags, Be the first to tag this record!